Parabilis Medicines, Inc. Payments of Stock Issuance Costs
Parabilis Medicines, Inc. (PBLS) reported Payments of Stock Issuance Costs of $680.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-13
- 2026-06-30: Payments of Stock Issuance Costs 6 month $680.00K.
- 2025-06-30: Payments of Stock Issuance Costs 6 month $62.00K.
| Period end | Payments of Stock Issuance Costs 6 month |
|---|---|
| 2026-06-30 | $680.00K 10-Q · filed 2026-08-13 |
| 2025-06-30 | $62.00K 10-Q · filed 2026-08-13 |